Human Pathology, volume 40, issue 10, pages 1512-1515

Hep G2 is a hepatoblastoma-derived cell line

López‐Terrada Dolores 1
Cheung Sau Wai
Finegold Milton J
Knowles B.B.
1
 
Department of Pathology, Baylor College of Medicine, Houston TX, USA.
Publication typeJournal Article
Publication date2009-10-01
Journal: Human Pathology
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor3.3
ISSN00468177, 15328392
Pathology and Forensic Medicine

Citations by journals

5
10
15
20
25
30
Oncology Letters
Oncology Letters, 29, 11.93%
Oncology Letters
29 publications, 11.93%
Molecular Medicine Reports
Molecular Medicine Reports, 20, 8.23%
Molecular Medicine Reports
20 publications, 8.23%
Oncology Reports
Oncology Reports, 12, 4.94%
Oncology Reports
12 publications, 4.94%
Experimental and Therapeutic Medicine
Experimental and Therapeutic Medicine, 11, 4.53%
Experimental and Therapeutic Medicine
11 publications, 4.53%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 7, 2.88%
International Journal of Molecular Sciences
7 publications, 2.88%
International Journal of Molecular Medicine
International Journal of Molecular Medicine, 7, 2.88%
International Journal of Molecular Medicine
7 publications, 2.88%
Cancers
Cancers, 7, 2.88%
Cancers
7 publications, 2.88%
Scientific Reports
Scientific Reports, 7, 2.88%
Scientific Reports
7 publications, 2.88%
PLoS ONE
PLoS ONE, 5, 2.06%
PLoS ONE
5 publications, 2.06%
Nature Communications
Nature Communications, 5, 2.06%
Nature Communications
5 publications, 2.06%
Oncotarget
Oncotarget, 4, 1.65%
Oncotarget
4 publications, 1.65%
International Journal of Oncology
International Journal of Oncology, 4, 1.65%
International Journal of Oncology
4 publications, 1.65%
Journal of Cellular Biotechnology
Journal of Cellular Biotechnology, 2, 0.82%
Journal of Cellular Biotechnology
2 publications, 0.82%
Cells
Cells, 2, 0.82%
Cells
2 publications, 0.82%
Cell Reports
Cell Reports, 2, 0.82%
Cell Reports
2 publications, 0.82%
Toxicology and Applied Pharmacology
Toxicology and Applied Pharmacology, 2, 0.82%
Toxicology and Applied Pharmacology
2 publications, 0.82%
Experimental Cell Research
Experimental Cell Research, 2, 0.82%
Experimental Cell Research
2 publications, 0.82%
Toxicology in Vitro
Toxicology in Vitro, 2, 0.82%
Toxicology in Vitro
2 publications, 0.82%
iScience
iScience, 2, 0.82%
iScience
2 publications, 0.82%
Journal of Hepatology
Journal of Hepatology, 2, 0.82%
Journal of Hepatology
2 publications, 0.82%
Pediatric Blood and Cancer
Pediatric Blood and Cancer, 2, 0.82%
Pediatric Blood and Cancer
2 publications, 0.82%
Clinical Cancer Research
Clinical Cancer Research, 2, 0.82%
Clinical Cancer Research
2 publications, 0.82%
Doklady Biochemistry and Biophysics
Doklady Biochemistry and Biophysics, 1, 0.41%
Doklady Biochemistry and Biophysics
1 publication, 0.41%
Biology Open
Biology Open, 1, 0.41%
Biology Open
1 publication, 0.41%
Tumor Biology
Tumor Biology, 1, 0.41%
Tumor Biology
1 publication, 0.41%
Biomedical Reports
Biomedical Reports, 1, 0.41%
Biomedical Reports
1 publication, 0.41%
Hepatology
Hepatology, 1, 0.41%
Hepatology
1 publication, 0.41%
Journal of Mechanics in Medicine and Biology
Journal of Mechanics in Medicine and Biology, 1, 0.41%
Journal of Mechanics in Medicine and Biology
1 publication, 0.41%
Communications Biology
Communications Biology, 1, 0.41%
Communications Biology
1 publication, 0.41%
5
10
15
20
25
30

Citations by publishers

10
20
30
40
50
60
70
80
90
Spandidos Publications
Spandidos Publications, 84, 34.57%
Spandidos Publications
84 publications, 34.57%
Springer Nature
Springer Nature, 28, 11.52%
Springer Nature
28 publications, 11.52%
Elsevier
Elsevier, 28, 11.52%
Elsevier
28 publications, 11.52%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 24, 9.88%
Multidisciplinary Digital Publishing Institute (MDPI)
24 publications, 9.88%
Wiley
Wiley, 15, 6.17%
Wiley
15 publications, 6.17%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 5, 2.06%
Public Library of Science (PLoS)
5 publications, 2.06%
Frontiers Media S.A.
Frontiers Media S.A., 5, 2.06%
Frontiers Media S.A.
5 publications, 2.06%
Impact Journals
Impact Journals, 4, 1.65%
Impact Journals
4 publications, 1.65%
American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR), 4, 1.65%
American Association for Cancer Research (AACR)
4 publications, 1.65%
Pleiades Publishing
Pleiades Publishing, 3, 1.23%
Pleiades Publishing
3 publications, 1.23%
IOS Press
IOS Press, 3, 1.23%
IOS Press
3 publications, 1.23%
SAGE
SAGE, 3, 1.23%
SAGE
3 publications, 1.23%
Oxford University Press
Oxford University Press, 3, 1.23%
Oxford University Press
3 publications, 1.23%
The Company of Biologists
The Company of Biologists, 1, 0.41%
The Company of Biologists
1 publication, 0.41%
World Scientific
World Scientific, 1, 0.41%
World Scientific
1 publication, 0.41%
Korean Association of Medical Journal Editors, 1, 0.41%
Korean Association of Medical Journal Editors
1 publication, 0.41%
King Saud University
King Saud University, 1, 0.41%
King Saud University
1 publication, 0.41%
American Society for Pharmacology and Experimental Therapeutics
American Society for Pharmacology and Experimental Therapeutics, 1, 0.41%
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.41%
V. N. Orekhovich Research Institute of Biomedical Chemistry
V. N. Orekhovich Research Institute of Biomedical Chemistry, 1, 0.41%
V. N. Orekhovich Research Institute of Biomedical Chemistry
1 publication, 0.41%
Taylor & Francis
Taylor & Francis, 1, 0.41%
Taylor & Francis
1 publication, 0.41%
IEEE
IEEE, 1, 0.41%
IEEE
1 publication, 0.41%
Japanese Society of Toxicology, 1, 0.41%
Japanese Society of Toxicology
1 publication, 0.41%
Hindawi Limited
Hindawi Limited, 1, 0.41%
Hindawi Limited
1 publication, 0.41%
The Korean Society for Applied Biological Chemistry, 1, 0.41%
The Korean Society for Applied Biological Chemistry
1 publication, 0.41%
eLife Sciences Publications
eLife Sciences Publications, 1, 0.41%
eLife Sciences Publications
1 publication, 0.41%
Cold Spring Harbor Laboratory
Cold Spring Harbor Laboratory, 1, 0.41%
Cold Spring Harbor Laboratory
1 publication, 0.41%
American Diabetes Association
American Diabetes Association, 1, 0.41%
American Diabetes Association
1 publication, 0.41%
Shi Jie Wei Chang Bing Xue Za Zhi She, 1, 0.41%
Shi Jie Wei Chang Bing Xue Za Zhi She
1 publication, 0.41%
Institute for Public Health of the National Academy of Medical Sciences of Ukraine, 1, 0.41%
Institute for Public Health of the National Academy of Medical Sciences of Ukraine
1 publication, 0.41%
10
20
30
40
50
60
70
80
90
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
López‐Terrada D. et al. Hep G2 is a hepatoblastoma-derived cell line // Human Pathology. 2009. Vol. 40. No. 10. pp. 1512-1515.
GOST all authors (up to 50) Copy
López‐Terrada D., Cheung S. W., Finegold M. J., Knowles B. Hep G2 is a hepatoblastoma-derived cell line // Human Pathology. 2009. Vol. 40. No. 10. pp. 1512-1515.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.humpath.2009.07.003
UR - https://doi.org/10.1016%2Fj.humpath.2009.07.003
TI - Hep G2 is a hepatoblastoma-derived cell line
T2 - Human Pathology
AU - López‐Terrada, Dolores
AU - Cheung, Sau Wai
AU - Finegold, Milton J
AU - Knowles, B.B.
PY - 2009
DA - 2009/10/01 00:00:00
PB - Elsevier
SP - 1512-1515
IS - 10
VL - 40
SN - 0046-8177
SN - 1532-8392
ER -
BibTex |
Cite this
BibTex Copy
@article{2009_López‐Terrada,
author = {Dolores López‐Terrada and Sau Wai Cheung and Milton J Finegold and B.B. Knowles},
title = {Hep G2 is a hepatoblastoma-derived cell line},
journal = {Human Pathology},
year = {2009},
volume = {40},
publisher = {Elsevier},
month = {oct},
url = {https://doi.org/10.1016%2Fj.humpath.2009.07.003},
number = {10},
pages = {1512--1515},
doi = {10.1016/j.humpath.2009.07.003}
}
MLA
Cite this
MLA Copy
López‐Terrada, Dolores, et al. “Hep G2 is a hepatoblastoma-derived cell line.” Human Pathology, vol. 40, no. 10, Oct. 2009, pp. 1512-1515. https://doi.org/10.1016%2Fj.humpath.2009.07.003.
Found error?